scispace - formally typeset
Open Access

ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof, +3 more
- Vol. 70, Iss: 1, pp 1-84
About
The article was published on 2017-01-01 and is currently open access. It has received 3603 citations till now. The article focuses on the topics: Management of atrial fibrillation.

read more

Citations
More filters
Journal ArticleDOI

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

TL;DR: Authors/Task Force Members: Piotr Ponikowski* (Chairperson) (Poland), Adriaan A. Voors* (Co-Chair person) (The Netherlands), Stefan D. Anker (Germany), Héctor Bueno (Spain), John G. F. Cleland (UK), Andrew J. S. Coats (UK)
Journal ArticleDOI

2018 ESC/EACTS Guidelines on myocardial revascularization.

TL;DR: Authors/Task Force Members: Franz-Josef Neumann* (ESC Chairperson) (Germany), Miguel Sousa-Uva* (EACTS Chair person) (Portugal), Anders Ahlsson (Sweden), Fernando Alfonso (Spain), Adrian P. Banning (UK), Umberto Benedetto (UK).
Journal ArticleDOI

2017 HRS / EHRA / ECAS / APHRS / SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

Hugh Calkins, +60 more
- 01 Oct 2017 - 
TL;DR: This 2017 Consensus Statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of AF and to report the findings of a writing group, convened by these five international societies.
References
More filters
Journal ArticleDOI

Postoperative Atrial Fibrillation Significantly Increases Mortality, Hospital Readmission, and Hospital Costs

TL;DR: New onset POAF is associated with increased risk-adjusted mortality, hospital costs, and readmission rates, and Protocols to reduce the incidence have the potential to significantly impact patient outcomes and the delivery of high-quality, cost-effective patient care.
Journal ArticleDOI

Irbesartan in Patients with Atrial Fibrillation

TL;DR: There was no benefit of irbesartan in preventing hospitalization for atrial fibrillation or atrialfibrillation recorded on 12-lead electrocardiography, nor was there a benefit in a subgroup that underwent transtelephonic monitoring.
Related Papers (5)